IBM ’ s Moonshot Ambition In Healthcare

This article is a part of our series Tech Giants In Healthcare. Previous titles included Amazon’s Dive Into Healthcare: A 2021 UpdateIs Apple Going Into Healthcare?Google’s Masterplan for HealthcareMicrosoft Makes a 16-billion Dollar Bet On Healthcare Take a deeper dive into what these companies aim for in medicine with our e-book, Tech Giants In Healthcare. Back in 2015, IBM’s previous CEO, Virginia Rometty famously said that IBM’s “moon shot will be the impact we have on healthcare.” Under the Watson Health banner, the tech company has been leveraging its expertise in cognitive computing to assist medical decision-making. In its wake, Watson Health attracted several partners and made a series of acquisitions to forge ahead of its vision. But in recent years, the tech giant’s moonshot ambition seems to have waned. It faced management issues and had to lay off part of its Watson Health workforce in 2018. After four years of working on a mission “to eradicate cancer” that cost over $62 million, the MD Anderson Cancer Center severed ties with IBM Watson. In fact, over a dozen of its clients and partners stopped or diminished their projects. The health A.I. branch also received wide criticism following reports that questioned its diagnostic prowess while pointing out potential risks to patients’ safety. Nevertheless, IBM still has some interest in the healthcare industry but recent developments indicate a change in trajectory in this fi...
Source: The Medical Futurist - Category: Information Technology Authors: Tags: Artificial Intelligence in Medicine Digital Health Research Future of Medicine Future of Pharma Health Sensors & Trackers Healthcare Design Personalized Medicine Portable Medical Diagnostics IBM ibm watson xprize A.I. quantum compu Source Type: blogs